| Janice Lee Mccabe, | |
|
126 Phoenix Ave, Building 2, Lowell, MA 01852-4931 | |
| (978) 453-8331 | |
| (978) 453-9254 |
| Full Name | Janice Lee Mccabe |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 126 Phoenix Ave, Lowell, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134300908 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 281 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Janice Lee Mccabe, 126 Phoenix Ave, Building 2, Lowell, MA 01852-4931 Ph: (978) 453-8331 | Janice Lee Mccabe, 126 Phoenix Ave, Building 2, Lowell, MA 01852-4931 Ph: (978) 453-8331 |
News Archive
Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced that it has signed an agreement to acquire Gambro's worldwide peritoneal dialysis (PD) business. Gambro has decided to prioritize its investments in the hemodialysis field. Fresenius Medical Care is taking advantage of this opportunity to expand its activities in the homecare market, especially in Europe and Asia-Pacific.
Researchers have discovered a key reason why a form of leukemia progresses from its more-treatable chronic phase to a life-threatening phase called blast crisis.
A third of women living with rheumatoid arthritis say their disease impacts their enjoyment of the festive season - Women living with rheumatoid arthritis find shopping for gifts, preparing holiday food, writing cards and wrapping presents most difficult to do - Nearly two thirds of women living with rheumatoid arthritis experience pain daily
City of Hope researchers received approval from the U.S. Food and Drug Administration (FDA) to conduct the first-in-human study of a neural stem cell-based therapy targeting recurrent high-grade gliomas, the most aggressive type of brain tumor. Karen S. Aboody, M.D., associate professor in City of Hope's Department of Neurosciences, leads the research team that developed this treatment strategy. Jana Portnow, M.D., assistant professor and assistant director of the Brain Tumor Program at City of Hope, is the principal investigator for the clinical trial.
Pivotal Therapeutics Inc., a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today the enrollment of the first patient in Pivotal's POMEGA Phase IIa clinical trial with PVT-100.
› Verified 4 days ago
Mrs. Rachel S Harty, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 126 Phoenix Ave, Lowell, MA 01852 Phone: 978-453-8331 | |
Crystal Hutchins, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 126 Phoenix Ave, Lowell, MA 01852 Phone: 978-453-8331 | |
Ms. Bonnie Jane Porter Couto, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 Warren Street, South Bay Early Intervention, Lowell, MA 01852 Phone: 978-452-1736 | |
Mrs. Natalie R Guerin, MS, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 126 Phoenix Ave, Lowell, MA 01852 Phone: 978-453-8331 | |
Ms. Bethany Ann Vinal, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 126 Phoenix Ave, Lowell Research, Building 2, Lowell, MA 01852 Phone: 978-453-8331 Fax: 978-453-9254 | |
Miss Courtney Elizabeth Lippe, MA CFY SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 126 Phoenix Ave, Lowell, MA 01852 Phone: 978-453-8331 | |
Ms. Donna V. Berman, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 295 Varnum Ave, Lowell, MA 01854 Phone: 978-937-6403 |